Sign in

CIK 0001609809

  • Non-accelerated filer
  • Smaller reporting company

Seres Therapeutics, Inc.

Sign in to watch
Ticker
MCRB
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
274326290
Phone
+1 617-945-9626
Business address
200 SIDNEY STREET, CAMBRIDGE, MA, 02139
Former names
Seres Therapeutics, Inc., Seres Health, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$795
in 4 filings, $795 under 10b5-1 plans

Net −$795. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2023-02-03 Ege David S. Grant or award · Stock Option (Right to Buy) +95,000 95,000
2023-02-03 von Moltke Lisa Grant or award · Restricted Stock Units +47,500 47,500
2023-02-03 von Moltke Lisa Grant or award · Stock Option (Right to Buy) +95,000 95,000
2023-02-03 Henn Matthew R. Grant or award · Restricted Stock Units +45,000 45,000
2023-02-03 Henn Matthew R. Grant or award · Stock Option (Right to Buy) +90,000 90,000
2023-02-03 DesRosier Thomas Chief Legal Officer and EVP Grant or award · Restricted Stock Units +42,500 42,500
2023-02-03 DesRosier Thomas Chief Legal Officer and EVP Grant or award · Stock Option (Right to Buy) +85,000 85,000
2023-02-03 Shaff Eric D. CEO and President Grant or award · Restricted Stock Units +125,000 125,000
2023-02-03 Shaff Eric D. CEO and President Grant or award · Stock Option (Right to Buy) +250,000 250,000
2023-02-03 Arkowitz David Chief Financial Officer Grant or award · Restricted Stock Units +42,500 42,500
2023-02-03 Arkowitz David Chief Financial Officer Grant or award · Stock Option (Right to Buy) +85,000 85,000
2023-02-03 Young Teresa L. Grant or award · Restricted Stock Units +42,500 42,500
2023-02-03 Young Teresa L. Grant or award · Restricted Stock Units +85,000 85,000
2023-02-03 Young Teresa L. Grant or award · Stock Option (Right to Buy) +85,000 85,000
2023-02-03 Cloghessy Paula Grant or award · Restricted Stock Units +47,500 47,500
2023-02-03 Cloghessy Paula Grant or award · Stock Option (Right to Buy) +95,000 95,000
2023-01-04 Fraser Claire Director Grant or award · Stock Option (right to buy) +48,000 48,000
2022-10-31 Ege David S. Sale −5,012 $7.93 $40K 46,734
2022-10-27 Ege David S. Grant or award +20,000 51,746
2022-10-27 Arkowitz David Chief Financial Officer Grant or award +42,500 112,992

Page 19 of 23 · 458 trades